Ozempic represents a sophisticated approach to managing Type 2 diabetes and supporting weight loss efforts. As a GLP-1 receptor agonist, the medication operates through a complex mechanism that ...

Here’s how it works. Weight-loss drugs that work like Ozempic can help users shed pounds. Now, a new study suggests the medications could also help people with alcohol use disorder. The research ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, including Ozempic and Wegovy. Millions more senior citizens and lower-income Americans could obtain ...

“Oh, oh, oh Ozempic, you know, never believe it’s not so!” It’s one of those inescapable, if not annoying little jingles that sticks in your head even if you have no idea what the commercial is about.

Kate DeAraugo has opened up about using Ozempic for weight loss following her impressive 12kg slim down. The singer, who won Australian Idol in 2005, has been documenting her journey on TikTok ...

As Ozempic and other GLP-1 drugs explode in popularity, driven by their off-label use for rapid weight loss and viral social media trends, the pharmaceutical industry faces unprecedented challenges.

Serena Williams is setting the record straight regarding speculation surrounding her bleached complexion. The tennis legend ...

Ahead of the January 16 release of Dynasty Warriors Origins, Koei Tecmo has launched a demo of the upcoming Musou on Steam, ...

That drug’s name is semaglutide. Most Americans know it as Ozempic or Wegovy, which is how Novo Nordisk markets two versions of the drug. Semaglutide has proved effective in treating diabetes and ...

This week it was kidney disease, according to a study that showed semaglutide — the active ingredient in medications sold under the brand names Ozempic, Rybelsus and Wegovy — may prevent kidney ...

To find out which version you are on, go to Settings in the app. Under the tutorial section is the version number. It is good to check you have the latest version that is available in the app store.